Tuning gut microbiota through a probiotic blend in gemcitabine-treated pancreatic cancer xenografted mice

Clin Transl Med. 2021 Nov;11(11):e580. doi: 10.1002/ctm2.580.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / pharmacology
  • Deoxycytidine / therapeutic use
  • Gastrointestinal Microbiome / drug effects*
  • Gemcitabine
  • Mice
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / genetics
  • Probiotics / pharmacology
  • Probiotics / therapeutic use
  • Transplantation, Heterologous / methods
  • Transplantation, Heterologous / statistics & numerical data

Substances

  • Deoxycytidine
  • Gemcitabine